Key result
DSE criteria predict true-severe AS and death in low-flow low-gradient aortic stenosis.
Why the study?
The study aimed to assess the value of guideline criteria to predict the presence of true-severe AS and the occurrence of death in patients with low-flow, low-gradient aortic stenosis.
Cohort (n=186)
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“If you increase the flow and remeasure the aortic valve area, you'll find that a lot of these patients don't have a really small aortic valve area of less than 1.0 cm2. You might find the aortic valve area pops up to 1.4-1.6 cm2.”
“Annabi et al provided strong evidence that these criteria are neither sensitive nor specific for identifying TSAS. Furthermore, because these parameters do not predict survival in medically treated patients, they are not ideal tools for identifying candidates for AVR.”
May aid low-flow, low-gradient aortic stenosis management; leaves open need for randomized confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Annabi et al. (2018) conducted a cohort in Low-flow, low-gradient aortic stenosis (LF-LG AS) (n=186). Dobutamine Stress Echocardiography (DSE) was evaluated on Presence of true-severe AS and occurrence of death. Dobutamine stress echocardiography criteria were evaluated for predicting true-severe aortic stenosis and death in a prospective cohort of 186 patients with low-flow, low-gradient aortic stenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: